Qingdao Vland Biotech INC. (SHA:603739)

SHA:603739 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	215.68	248.73	239.6	213.87	311.83	249.92
Trading Asset Securities	223.1	199.34	292.05	212.02	170.43	97.45
Cash & Short-Term Investments	438.78	448.07	531.64	425.89	482.27	347.37
Cash Growth	-12.34%	-15.72%	24.83%	-11.69%	38.83%	-2.69%
Accounts Receivable	424.76	376.58	330.26	307.72	254.31	193.55
Other Receivables	40.17	28.68	25.83	32.51	36.3	21.81
Receivables	464.93	405.26	356.09	347.91	298.37	220.55
Inventory	216.74	188.95	205.41	173.63	157.02	124.73
Prepaid Expenses	-	1.59	0.12	0.13	0.06	0.12
Other Current Assets	28.84	25.31	30.68	21.84	34.1	49.45
Total Current Assets	1,149	1,069	1,124	969.4	971.82	742.22
Property, Plant & Equipment	1,522	1,560	1,505	1,260	843.51	501.01
Long-Term Investments	94.58	98.64	80.84	77.19	8.59	16.14
Goodwill	84.2	84.2	84.2	20.26	20.26	9.9
Other Intangible Assets	127.32	131.13	139.74	135.63	131.46	122.25
Long-Term Deferred Tax Assets	22.49	16.99	18.06	13.64	12.03	8.91
Long-Term Deferred Charges	1.6	1.47	1.41	1.28	0.37	0.24
Other Long-Term Assets	40.31	19.14	80.57	101.57	233.72	50.79
Total Assets	3,042	2,981	3,034	2,579	2,222	1,451
Accounts Payable	204.13	224.56	231.95	147.36	112.11	86.74
Accrued Expenses	32.99	102.09	91.76	74.26	72.89	74.52
Short-Term Debt	608.52	581.63	568.97	374.22	135.93	67.83
Current Portion of Long-Term Debt	62.32	40.03	92.88	-	1	-
Current Income Taxes Payable	18.58	10.06	8.43	11.67	8.95	1.86
Current Unearned Revenue	16.29	11.51	10.67	7.49	13.62	12.43
Other Current Liabilities	120.51	61.57	83.51	30.1	27.83	29.42
Total Current Liabilities	1,063	1,031	1,088	645.09	372.33	272.8
Long-Term Debt	13.81	13.96	62.06	149	99	-
Long-Term Unearned Revenue	60.84	63.97	55.26	47.96	60.45	55.66
Long-Term Deferred Tax Liabilities	2.34	1.46	3.02	2.72	2.88	1.24
Other Long-Term Liabilities	-	0.15	0.15	0.17	1.52	6.52
Total Liabilities	1,140	1,111	1,209	844.93	536.18	336.22
Common Stock	253.03	253.03	253.03	252.44	252.08	154.67
Additional Paid-In Capital	702.9	702.9	712.08	705.09	693.84	308.36
Retained Earnings	833.37	796.9	759.56	704.12	674.61	578.05
Comprehensive Income & Other	-15.27	-15.1	-16.38	-16.96	-16.03	-6.95
Total Common Equity	1,774	1,738	1,708	1,645	1,605	1,034
Minority Interest	127.18	132.3	117.09	89.22	81.07	81.12
Shareholders' Equity	1,901	1,870	1,825	1,734	1,686	1,115
Total Liabilities & Equity	3,042	2,981	3,034	2,579	2,222	1,451
Total Debt	684.65	635.62	723.92	523.22	235.93	67.83
Net Cash (Debt)	-245.87	-187.55	-192.27	-97.33	246.34	279.54
Net Cash Growth	-	-	-	-	-11.88%	-12.66%
Net Cash Per Share	-0.98	-0.75	-0.76	-0.38	1.00	1.23
Filing Date Shares Outstanding	253.03	253.03	253.03	252.62	252.08	216.53
Total Common Shares Outstanding	253.03	253.03	253.03	252.44	252.08	216.53
Working Capital	85.94	37.75	35.77	324.31	599.5	469.43
Book Value Per Share	7.01	6.87	6.75	6.52	6.36	4.78
Tangible Book Value	1,563	1,522	1,484	1,489	1,453	901.98
Tangible Book Value Per Share	6.18	6.02	5.87	5.90	5.76	4.17
Buildings	-	932.34	931.6	449.85	398.83	313.52
Machinery	-	943.65	929.21	474.19	443.58	340.44
Construction In Progress	-	203.81	75.14	704.43	315.72	122.58

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.